Watal, Jayashree. 2001. on Differential Pricing and Financing of Essential “Workshop Drugs: Background Note.” WTO Secretariat. World Health Organization. 2001. Equitable Pricing for Essential Drugs: What “More do we Mean and what are the Issues?” Background paper for the WHO-WTO secretariat workshop on differential pricing and financing of essential drugs. World Health Organization. 2001b. of the Workshop on Differential Pricing and “Report Financing of Essential Drugs.” Health Organization. 2006. to AIDS medicines stumbles on trade rules.” “Access http://www.who.int/bulletin/volumes/84/5/news10506/en/#. World Health Organization. 2007. Essential Medicines Price Indicator.” “Afro World Health Organization. 2008. edges closer to AIDS treatment for all.” “Uganda www.who.int/bulletin/volumes/86/6/08-020608/en/. World Health Organization. 2013. Price Reporting Mechanism.” . “Global World Health Organization. 2013(b). Report on HIV Treatment: Results, “Global Impacts, and Opportunities.” Health Organization. 2014. Doha Declaration on the TRIPS Agreement and “The Public Health.” http://www.who.int/medicines/areas/policy/doha_declaration/en/. World Trade Organization. Agreement.” Signed 1994.. “Trips Trade Organization. 2001. Attending the Fourth WTO Ministerial “NGOs Conference, Doha, Qatar 9-13 November 2001.” . World Trade Organization. 2001. Non-governmental Organisations Eligible to “647 Attend the Doha Ministerial.” . World Trade Organization. 2001. Declaration on the TRIPS Agreement and “Doha Public Health.” . World Trade Organization. 2001. Country Group’s Paper.” . “Developing World Trade Organization. 2001. Paper.” . “EU’s World Trade Organization. 2009. Access to Antiretroviral Therapy: The “Universal Brazilian Experience.”
Watal, Jayashree. 2001. “Workshop on Differential Pricing and Financing of Essential Drugs: Background Note.” WTO Secretariat. World Health Organization. 2001. “More Equitable Pricing for Essential Drugs: What do we Mean and what are the Issues?” Background paper for the WHO-WTO secretariat workshop on differential pricing and financing of essential drugs. World Health Organization. 2001b. “Report of the Workshop on Differential Pricing and Financing of Essential Drugs.” Health Organization. 2006. “Access to AIDS medicines stumbles on trade rules.” http://www.who.int/bulletin/volumes/84/5/news10506/en/#. World Health Organization. 2007. “Afro Essential Medicines Price Indicator.” World Health Organization. 2008. “Uganda edges closer to AIDS treatment for all.” www.who.int/bulletin/volumes/86/6/08-020608/en/. World Health Organization. 2013. “Global Price Reporting Mechanism.” . World Health Organization. 2013(b). “Global Report on HIV Treatment: Results, Impacts, and Opportunities.” Health Organization. 2014. “The Doha Declaration on the TRIPS Agreement and Public Health.” http://www.who.int/medicines/areas/policy/doha_declaration/en/. World Trade Organization. “Trips Agreement.” Signed 1994.. Trade Organization. 2001. “NGOs Attending the Fourth WTO Ministerial Conference, Doha, Qatar 9-13 November 2001.” . World Trade Organization. 2001. “647 Non-governmental Organisations Eligible to Attend the Doha Ministerial.” . World Trade Organization. 2001. “Doha Declaration on the TRIPS Agreement and Public Health.” . World Trade Organization. 2001. “Developing Country Group’s Paper.” . World Trade Organization. 2001. “EU’s Paper.” . World Trade Organization. 2009. “Universal Access to Antiretroviral Therapy: The Brazilian Experience.”
Creating_The_World_Market_for_Lifesaving_AIDS_Drugs.docx